Analysis of the nonperfused volume ratio of adenomyosis from MRI images based on fewshot learning
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
A few-shot learning framework was developed to predict the nonperfused volume ratio of adenomyosis from MRI images, achieving an area under the curve of 0.8375 for NPV ratio classification.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The nonperfused volume (NPV) ratio is the key to the success of high intensity focused ultrasound (HIFU) ablation treatment of adenomyosis. However, there are no qualitative interpretation standards for predicting the NPV ratio of adenomyosis using magnetic resonance imaging (MRI) before HIFU ablation treatment, which leading to inter-reader variability. Convolutional neural networks (CNNs) have achieved state-of-the-art performance in the automatic disease diagnosis of MRI. Since the use of HIFU to treat adenomyosis is a novel treatment, there is not enough MRI data to support CNNs. We proposed a novel few-shot learning framework that extends CNNs to predict NPV ratio of HIFU ablation treatment for adenomyosis. We collected a dataset from 208 patients with adenomyosis who underwent MRI examination before and after HIFU treatment. Our proposed method was trained and evaluated by fourfold cross validation. This framework obtained sensitivity of 85.6%, 89.6% and 92.8% at 0.799, 0.980 and 1.180 FPs per patient. In the receiver operating characteristics analysis for NPV ratio of adenomyosis, our proposed method received the area under the curve of 0.8233, 0.8289, 0.8412, 0.8319, 0.7010, 0.7637, 0.8375, 0.8219, 0.8207, 0.9812 for the classifications of NPV ratio interval [0%-10%), [10%-20%), …, [90%-100%], respectively. The present study demonstrated that few-shot learning on NPV ratio prediction of HIFU ablation treatment for adenomyosis may contribute to the selection of eligible patients and the pre-judgment of clinical efficacy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis 2016
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis 2009
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis 2018
Cited by (2)
References (61)
- Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis via openalex
- Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis via openalex
- Safety and Efficacy of High Intensity Focused Ultrasound Ablation Therapy for Adenomyosis via openalex
- W2154158661 via openalex
- W2165698076 via openalex
- W2441649867 via openalex
- W2601450892 via openalex
- W2604297385 via openalex
- W2604763608 via openalex
- W2766530444 via openalex
- W2791172704 via openalex
- W2808168184 via openalex
- W2808498263 via openalex
- W2884848653 via openalex
- W2889609823 via openalex
- W2900206120 via openalex
- W2904415434 via openalex
- W2908875379 via openalex
- W2913969639 via openalex
- W2919308409 via openalex
- W2919392656 via openalex
- W2924927402 via openalex
- W2935787471 via openalex
- W2944138435 via openalex
- W2945052290 via openalex
- W2951775809 via openalex
- W2952825522 via openalex
- W2955189540 via openalex
- W2958149692 via openalex
- W2963131975 via openalex
- W2963341924 via openalex
- W2963516100 via openalex
- W2963551321 via openalex
- W2963943197 via openalex
- W2964249870 via openalex
- W2965607502 via openalex
- W2972037190 via openalex
- W2977457995 via openalex
- W2979653841 via openalex
- W2979808779 via openalex
- W2981101506 via openalex
- W2981753123 via openalex
- W2981767205 via openalex
- W2982790269 via openalex
- W2984254165 via openalex
- W2991257700 via openalex
- W2991642257 via openalex
- W2992196493 via openalex
- W2995378448 via openalex
- W3000029017 via openalex
- W3003770199 via openalex
- W3099591453 via openalex
- W6717697761 via openalex
- W6735236233 via openalex
- W6735741670 via openalex
- W6736057607 via openalex
- W6749327742 via openalex
- W1997499435 via openalex
- W6752940074 via openalex
- W2054264645 via openalex
- W2117340355 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:21:30.380497+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK